Literature DB >> 20491829

Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.

C Yao1, T Zhu, Y Li, L Zhang, B Zhang, J Huang, W Fu.   

Abstract

The emergence of multidrug-resistance Mycobacterium tuberculosis is an increasing threat to tuberculosis control programmes. Susceptibility testing of Mycobacterium tuberculosis complex isolates by traditional methods requires a minimum of 14 days. This can be reduced significantly if molecular analysis is used. DNA sequencing is a good method for detecting mutation, but cannot be used routinely because of its relatively high cost. A sensitive and specific microarray has been designed to detect mutations in the rifampin resistance determining region of rpoB and loci in katG and inhA associated with isoniazid (INH) resistance. A panel of Mycobacterium tuberculosis isolates containing 13 different rpoB genotypes, two mutation genotypes within codon 315 of katG and one mutation genotypes at inhA was used to validate the microarray. The results obtained indicate that 100% of rifampicin-resistant M. tuberculosis strains isolated in Chongqing had rpoB mutations, with 531-Ser and 526-His being the most common positions substituted. Of the total 50 INH resistant isolates, 82% had a katG315 mutation and 18% had an inhA mutation. All the mutations detected by the microarray method were also confirmed by conventional DNA sequencing. It is demonstrated that the microarray is an efficient, specialized technique and can be used as a rapid method for detecting rifampin and isoniazid resistance.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20491829     DOI: 10.1111/j.1469-0691.2010.03267.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: a retrospective analysis of thirty-five patients.

Authors:  Litao Li; Zehua Zhang; Fei Luo; Jianzhong Xu; Peng Cheng; Zheng Wu; Qiang Zhou; Qingyi He; Fei Dai; Jian Wang; Jinsong Zhang
Journal:  Int Orthop       Date:  2011-11-09       Impact factor: 3.075

2.  "Spoligoriftyping," a dual-priming-oligonucleotide-based direct-hybridization assay for tuberculosis control with a multianalyte microbead-based hybridization system.

Authors:  Michel Kiréopori Gomgnimbou; Edgar Abadia; Jian Zhang; Guislaine Refrégier; Stefan Panaiotov; Elizabeta Bachiyska; Christophe Sola
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

3.  Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray.

Authors:  Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Peter Qu; Christopher Knickerbocker; Christopher G Cooney; Darrell P Chandler
Journal:  J Vis Exp       Date:  2014-04-25       Impact factor: 1.355

Review 4.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

5.  Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis.

Authors:  Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Amine Lambarqui; Lexi Bryant; George B Rudy; Kim Dionne; Stefanie L Fisher; Nicole Parrish; Darrell P Chandler
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

6.  Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis isolates from clinical specimens.

Authors:  Xiaoyou Chen; Bin Wang; Wen Yang; Fanrong Kong; Chuanyou Li; Zhaogang Sun; Peter Jelfs; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

7.  Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.

Authors:  Jainagul Isakova; Nurmira Sovkhozova; Denis Vinnikov; Zoy Goncharova; Elnura Talaibekova; Nazira Aldasheva; Almaz Aldashev
Journal:  BMC Microbiol       Date:  2018-03-22       Impact factor: 3.605

8.  Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.

Authors:  Yvonne Linger; Christopher Knickerbocker; David Sipes; Julia Golova; Molly Franke; Roger Calderon; Leonid Lecca; Nitu Thakore; Rebecca Holmberg; Peter Qu; Alexander Kukhtin; Megan B Murray; Christopher G Cooney; Darrell P Chandler
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

9.  Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tuberculosis in sputum samples.

Authors:  Wei Lu; Cheng Chen; Yan Shao; Jinyan Shi; Chongqiao Zhong; Dandan Yang; Honghuan Song; Guoli Li; Xiaoyan Ding; Hong Peng; Linyang Zhu; Yang Zhou; Limei Zhu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.

Authors:  Zehua Zhang; Litao Li; Fei Luo; Peng Cheng; Feng Wu; Zheng Wu; Tianyong Hou; Min Zhong; Jianzhong Xu
Journal:  BMC Infect Dis       Date:  2012-11-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.